Lupus Nephritis in Men: A Series of 25 Cases
Archives of Men's Health,
Vol. 8 No. 1 (2024),
31 July 2024,
Page e13
https://doi.org/10.22037/amh.v8i1.48947
Introduction: Systemic lupus erythematosus (SLE) is an autoimmune disease more common in women than in men. This study analyzes the clinical, biological, immunological, and evolutionary features of lupus nephritis in men. Methods: This study involved 25 male patients diagnosed with lupus nephritis between 2020 and 2024, selected from 90 lupus patients. All met the ACR or SLICC criteria and had kidney damage. Results: The average age at diagnosis was 34.2 years (range: 16–51). Six patients were hypertensive, none were diabetic. Renal failure was observed in 15 patients, hematuria in 12, nephrotic syndrome in 15, and non-nephrotic proteinuria in 8. Most patients had lupus membranoproliferative glomerulonephritis (Class IV, 19 patients), followed by extra-membranous glomerulonephritis (Class V, 4 patients). Extra-renal involvement included hematological disorders (18 patients) and joint issues (16 patients), with two patients having antiphospholipid syndrome. For treatment, 21 patients received intravenous methylprednisolone and cyclophosphamide, while 4 received oral mycophenolate mofetil (MMF). Maintenance therapy was with MMF (4 patients) or azathioprine (15 patients). After two years, 8 patients achieved complete remission, 2 had partial remission, 5 relapsed, and 4 progressed to chronic kidney disease, including 2 with end-stage renal disease. Conclusion: Lupus nephritis generally has a favorable course, although relapses and chronic kidney disease are observed. Personalized management is crucial for improving long-term outcomes.